267 related articles for article (PubMed ID: 8942719)
1. Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia.
Annese V; Basciani M; Perri F; Lombardi G; Frusciante V; Simone P; Andriulli A; Vantrappen G
Gastroenterology; 1996 Dec; 111(6):1418-24. PubMed ID: 8942719
[TBL] [Abstract][Full Text] [Related]
2. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up.
Allescher HD; Storr M; Seige M; Gonzales-Donoso R; Ott R; Born P; Frimberger E; Weigert N; Stier A; Kurjak M; Rösch T; Classen M
Endoscopy; 2001 Dec; 33(12):1007-17. PubMed ID: 11740642
[TBL] [Abstract][Full Text] [Related]
3. Intrasphincteric botulinum toxin for the treatment of achalasia.
Pasricha PJ; Ravich WJ; Hendrix TR; Sostre S; Jones B; Kalloo AN
N Engl J Med; 1995 Mar; 332(12):774-8. PubMed ID: 7862180
[TBL] [Abstract][Full Text] [Related]
4. Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost minimization analysis.
Panaccione R; Gregor JC; Reynolds RP; Preiksaitis HG
Gastrointest Endosc; 1999 Oct; 50(4):492-8. PubMed ID: 10502169
[TBL] [Abstract][Full Text] [Related]
5. Use of high-resolution endoscopic ultrasonography to assess esophageal wall damage after pneumatic dilation and botulinum toxin injection to treat achalasia.
Schiano TD; Fisher RS; Parkman HP; Cohen S; Dabezies M; Miller LS
Gastrointest Endosc; 1996 Aug; 44(2):151-7. PubMed ID: 8858320
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia.
Mikaeli J; Fazel A; Montazeri G; Yaghoobi M; Malekzadeh R
Aliment Pharmacol Ther; 2001 Sep; 15(9):1389-96. PubMed ID: 11552910
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of balloon dilation versus botulinum toxin injection in patients with primary achalasia.
Jung HE; Lee JS; Lee TH; Kim JN; Hong SJ; Kim JO; Kim HG; Jeon SR; Cho JY
Korean J Intern Med; 2014 Nov; 29(6):738-45. PubMed ID: 25378972
[TBL] [Abstract][Full Text] [Related]
8. Esophageal achalasia: intrasphincteric injection of botulinum toxin A versus balloon dilation.
Muehldorfer SM; Schneider TH; Hochberger J; Martus P; Hahn EG; Ell C
Endoscopy; 1999 Sep; 31(7):517-21. PubMed ID: 10533734
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of intrasphincteric botulinum toxin A injection versus balloon dilatation in treatment of achalasia cardia.
Ghoshal UC; Chaudhuri S; Pal BB; Dhar K; Ray G; Banerjee PK
Dis Esophagus; 2001; 14(3-4):227-31. PubMed ID: 11869325
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial.
Vaezi MF; Richter JE; Wilcox CM; Schroeder PL; Birgisson S; Slaughter RL; Koehler RE; Baker ME
Gut; 1999 Feb; 44(2):231-9. PubMed ID: 9895383
[TBL] [Abstract][Full Text] [Related]
11. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients.
Gordon JM; Eaker EY
Am J Gastroenterol; 1997 Oct; 92(10):1812-7. PubMed ID: 9382042
[TBL] [Abstract][Full Text] [Related]
13. Use of botulinum toxin as a diagnostic/therapeutic trial to help clarify an indication for definitive therapy in patients with achalasia.
Katzka DA; Castell DO
Am J Gastroenterol; 1999 Mar; 94(3):637-42. PubMed ID: 10086644
[TBL] [Abstract][Full Text] [Related]
14. Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment.
Storr M; Born P; Frimberger E; Weigert N; Rösch T; Meining A; Classen M; Allescher HD
BMC Gastroenterol; 2002 Aug; 2():19. PubMed ID: 12175425
[TBL] [Abstract][Full Text] [Related]
15. Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial.
Mikaeli J; Bishehsari F; Montazeri G; Mahdavinia M; Yaghoobi M; Darvish-Moghadam S; Farrokhi F; Shirani S; Estakhri A; Malekzadeh R
Aliment Pharmacol Ther; 2006 Sep; 24(6):983-9. PubMed ID: 16948810
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter.
Fishman VM; Parkman HP; Schiano TD; Hills C; Dabezies MA; Cohen S; Fisher RS; Miller LS
Am J Gastroenterol; 1996 Sep; 91(9):1724-30. PubMed ID: 8792688
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach.
Prakash C; Freedland KE; Chan MF; Clouse RE
Am J Gastroenterol; 1999 Feb; 94(2):328-33. PubMed ID: 10022624
[TBL] [Abstract][Full Text] [Related]
18. Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia.
Bansal R; Nostrant TT; Scheiman JM; Koshy S; Barnett JL; Elta GH; Chey WD
J Clin Gastroenterol; 2003 Mar; 36(3):209-14. PubMed ID: 12590230
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of achalasia patients treated with botulinum toxin.
D'Onofrio V; Miletto P; Leandro G; Iaquinto G
Dig Liver Dis; 2002 Feb; 34(2):105-10. PubMed ID: 11926552
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pneumatic dilation with pneumatic dilation plus botulinum toxin for treatment of achalasia.
Bakhshipour A; Rabbani R; Shirani S; Soleimani HA; Mikaeli J
Acta Med Iran; 2010; 48(2):107-10. PubMed ID: 21133003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
